The comparative effects of calcium channel blockers in an experimental colitis model in rats

Turkish Journal of Gastroenterology

Volumn 15, Issue 4, 2004, Pages 243-249

  Zeytunlu, Murat ^a,b   Korkut, Mustafa ^a   Akgün, Erhan ^a   Firat, Özgür ^a   Aynaci, Murat ^a   Icöz, Gökhan ^a   Kiliç, Murat ^a   Ersin, Sinan ^a   Özütemiz, Ömer ^a  

^a EGE UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acetic acid colitis; Diltiazem; Inflammatory bowel disease; Verapamil

Indexed keywords

ACETIC ACID; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; ENEMA; MYELOPEROXIDASE; VERAPAMIL;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON INJURY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; MALE; MICROSCOPY; NONHUMAN; RAT;

ANIMALS; CALCIUM CHANNEL BLOCKERS; COLITIS; DILTIAZEM; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; MALE; PEROXIDASE; RATS; VERAPAMIL;

EID: 13244275170     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. 4 by colonic mucosal inflammatory bowel disease. Gastroenterology 1984; 86: 453-60.
2. Sharon P, Stenson WF. Metabolism of arachidonic acid in acetic acid induced colitis in rats. Similarity to human inflammatory bowel disease. Gastroenterology 1985; 88: 55-63.
3. Rampton DS. Functional aspects of eicosanoids in inflamatory bowel disease. Eur J Gastroenterol Hepatol 1989; 1:145-9.
4. Fedorak RN, Empey LR, MacArthur C, et al. Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats. Gastroenterology 1990; 98: 615-25.
5. Wallace JL, MacNaughton WK, Morris GP, Beck PL. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989; 96: 29-36.
6. 2 inhibitors on acetic acid-induced acute colitis in the rat. Br J Surg 1993; 80: 1199-1204.
7. Fedorak RN, Empey LR, Walker K. Verapamil alters eicosanoid synthesis and accelerates healing during experimental colitis in rats. Gastroenterology 1992; 102: 1229-35.
8. Kaever V, Pfannkuche HJ, Wessel K, et al. The ratio of macrophage prostaglandin and leukotriene synthesis is determined by the intracellular free calcium level. Biochem Pharmacol 1990; 39: 1313-9.
9. Dixon RAF, Diehl RE, Opas E, et al. Requirement of a 5-lipoxygenase- activating protein for leukotriene synthesis. Nature 1990; 343: 282-4.
10. Miller DK, Gillard JW, Vickers PJ, et al. Identification and isolation of a membrane protein necessary for leukotriene production. Nature 1990; 343: 278-81.
11. Barrett TA, Musch MW, Vaitla R, et al. Differential regulation of lipoxygenase metabolism of arachidonic acid in isolated rabbit colonic macrophages (Abstract). Gastroenterology 1989; 93: 29.
12. 2 during stress. J Surg Res 1990; 49: 34-6.
13. Fabia R, Willen R, Ar'Rajab A, et al. Acetic acid-induced colitis in the rat. A reproducible experimental model for acute ulcerative colitis. Eur Surg Res 1992; 24: 211-25.
14. Maggi CA, Grimaldi G, Meli A. The effects of nifedipine and verapamil on high K+ induced contractions of the rat intestinal tract in vivo. Jpn J Pharmacol 1983; 27: 9-14.
15. Myers BS, Martin JS, Dempsey DT, et al. Acute experimental colitis decreases colonic circular smooth muscle contractility in rats. Am J Physiol 1997; 273: 928-36.
16. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344-50.
17. Louis E, Satsangi J. Cytokine gene polymorphisms in inflammatory bowel disease. Gut 1996; 39: 705-10.
18. Shanahan F. Pathogenesis of ulcerative colitis. Gastroenterology 1993; 342: 407-11.
19. 2 inhibition prevents mucosal damage associated with small intestinal ischemia in rats. Gut 1988; 29: 489-94.
20. Sharpstone DR, Duggal A, Gazzard BG. Inflammatory bowel disease in individuals seropositive for the human immunodeficiency virus. Eur J Gastroenterol Hepatol 1996; 8: 575-8.
21. Yamada T, Specian RD, Granger DN, et al. Misoprostol attenuates acetic-acid induced increases in mucosal permeability and inflammation: role of blood flow. Am J Physiol 1991; 261: 332-9.
22. Boehmen MW, Autschbach F, Zuna I. Elevated serum levels and reduced immunohistochemical expression of thrombomodulin in active ulcerative colitis. Gastroenterology 1997; 113: 107-17.
23. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986; 251: 567-74.
24. 4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 1986; 9: 837-44.
25. Keighley MRB, Williams NS. Surgery of the Anus, Rectum and Colon. W.B. Saunders Company Ltd. 1993.
26. Castell DO. Calcium channel blocking agents for gastrointestinal disorders. Am J Cardiol 1985; 55: 210-3.
27. Traube M, McCallum RW. Calcium-channel blockers and the gastrointestinal tract. Am J Gastroenterol 1984; 79: 892-6.
28. 2 and oxygenated free radicals in mucosa damage after small intestinal ischemia and reperfusion. Am J Surg 1989; 157: 562-5.
29. Bryant LR. An evaluation of the effect of fibrinolysin on intraperitoneal adhesion formation. Am J Surg 1973; 106: 892.